Chemoimmunotherapy and Radiation in Pancreatic Cancer

Completed · Phase 1

Conditions studied: Locally Advanced Malignant Neoplasm

In brief

The goal of this study is to evaluate the safety of combination treatment that includes chemotherapy, radiation therapy, and immunotherapy in patients with pancreatic cancer.

Key facts

Study ID
NCT01903083
Run by
Providence Health & Services
People needed
10
Starts
2013-07-01
Expected to finish
2017-12-01
Last updated by the study team
2018-02-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.